Advertisement

Topics

Companies Related to "Efficacy of Treatment for Panic Disorder" [Most Relevant Company Matches] - Page: 2 RSS

12:48 EDT 19th March 2019 | BioPortfolio

Here are the most relevant search results for "Efficacy of Treatment for Panic Disorder" found in our extensive corporate database of over 50,000 company records.

Showing "Efficacy Treatment Panic Disorder" Companies 26–50 of 3,600+

Relevant

D-Pharm Ltd

D-Pharm (http://www.dpharm.com) is a technology-driven biopharmaceutical company focused on the discovery and development of innovative proprietary drugs for the treatment of central nervous system disorders and cancer. D-Pharm is a leader in design and development of lipid-like medicine and its products are new chemical entities (NCEs) derived from its proprietary platform technology. The dru...


Ruttenberg Autism Center

Ruttenberg Autism Center, established by The Center for Autism and guided by the values and principles of Dr. Bertram A. Ruttenberg, is a suburban Philadelphia-based, fee-for-service organization providing treatment services for the lifespan of Autism Spectrum Disorder. Ruttenberg Autism Center’s team of clinicians specializes in effective, evidence-b...

The International Rett Syndrome Foundation

While there are over 3,800 known cases of Rett Syndrome in the United States which predominantly strikes only girls, the disorder is genetically linked to more widespread neurological disorders such as autism and schizophrenia. Rett symptoms begin to manifest between the first six to eighteen months of life and in most cases will eventually incapacitate the afflicted children so that they can...


NeuroDerm Ltd

NeuroDerm is an emerging pharmaceutical company that develops therapeutic dermal patches for the treatment of CNS diseases. NeuroDerm's technology is based on proprietary reformulations of well established oral drugs whose low bio-availability is the major impediment to better efficacy. The company's lead product is ND0611, a revolutionary skin patch for the treatment of Parkinson's disease. O...

Dr. Sam Goldstein

Sam Goldstein, Ph.D., is a member of the faculty at the University of Utah and in private practice at the Neurology, Learning and Behavior Center (N.L.B.C.) in Salt Lake City, Utah. He is on staff at the Primary Children’s Medical Center and the University Neuropsychiatric Institute. Dr. Goldstein has served as Chairman of the National Professional Advisory Board for the organization Children an...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

DEBRA

Epidermolysis Bullosa (EB) is a rare genetic disorder characterized by the presence of extremely fragile skin and recurrent blister formation, resulting from minor mechanical friction or trauma. Secondary complications can include infections, oral ulcerations, dental decay, esophageal blistering, corneal erosions, osteoporosis and psychological trauma. Thi...

TxFinder

CENTRAL NERVOUS SYSTEM DISORDERSTARGETED GENOMIC SAMPLE COLLECTIONTxFinder contracts with pharmaceutical companies, genomics companies and other biotech companies to collect targeted blood samples from individuals with CNS diseases.We can collect a large number of targeted blood samples in a short period of time. We make more than 1500 direct, unduplicated CNS patient contacts per month. Through...

Seabook House, National Alcohol & Drug Addiction Recovery Month

The goal of National Alcohol & Drug Addiction Recovery Month is to bring together people with substance use disorders, their families and treatment providers to share stories and empower others to take the necessary steps toward recovery. The Recovery Month effort aims to promote the societal benefits of alcohol and drug use disorder treatment, laud the contributions of treatment providers and...

GBS/CIDP Foundation

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in persons of any age. CIDP is a rare disorder of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a lesser ext...

Targacept, Inc.

Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, a unique class of proteins that regulate vital biological functions that are impaired in various disease states. Tar...

Cureveda LLC

Cureveda LLC was co-founded in 2010 by Johns Hopkins Bloomberg School of Public Health faculty members Shyam Biswal and Rajesh Thimmulappa together with Christy Wyskiel. The company is focused on the discovery, development and commercialization of drugs for the treatment of inflammatory, autoimmune and neurogenerative diseases. Cureveda is developing Nrf2 ...

Adlon Therapeutics L.P.

Adlon Therapeutics L.P. is a biopharmaceutical company dedicated to developing and providing treatment options for Attention-Deficit/Hyperactivity Disorder (ADHD) and related disorders. Our initial focus is on adults and adolescents who have been diagnosed with ADHD. Adlon is a subsidiary of Purdue Pharma L.P. For more information, please visit www.adlont...

MacuSight, Inc.

MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part...

Oxigene

OXiGENE, Inc. is an international biopharmaceutical company engaged principally in research into and thedevelopment of products for use in the treatment of cancer. Historically, the Company's activities have been directed primarily towards products designed to complement and enhance the clinical efficacy of radiation and chemotherapy,which are the most common and tradit...

Streamline Healthcare Solutions

Since the 1970’s, Comprehensive Healthcare has been providing services to children, adults and families throughout Eastern Washington. Comprehensive is a private, non-profit organization that offers a full range of behavioral health and substance abuse disorder treatment services, with special programs for veterans, victims of crime, parents and emplo...

Probably Relevant

Quadrant Biosciences, Inc.

Quadrant Biosciences, Inc. is developing clinical assessment and molecular diagnostic tools to help physicians assess brain health and support more rapid accurate diagnoses of brain-based disorders. The company’s tests are expected to improve the diagnosis, monitoring and treatment of serious health conditions including autism spectrum disorder, concu...

Neuromod Devices Limited

Neuromod, headquartered in the Digital Hub, Dublin, Ireland, is an emerging medical technology company, specialising in the design and development of neuromodulation technologies to address the clinical needs of underserved patient populations who live with chronic and debilitating conditions. The company was founded in 2010, by Dr. Ross O’Neill, as a...

CiTrials

At Clinical Innovations, our mission is to conduct Phase I-IV clinical trials in order to further the development of medications benefiting patients, communities, and physicians around the globe. Located in Southern California, CiTrials has the experience and expertise in performing Psychiatric and Internal medicine trials. From pediatric, first in human, single and multiple ascending dose, and...

Houston Headache Clinic

The Houston Headache Clinic, widely recognized as one of the premiere headache centers in the country, was established in 1976 for the diagnosis and management of headache problems. The physicians and staff of the Houston Headache Clinic treat each patient as a partner in the treatment of his or her own headache disorder, and patient education is central to this practice. Physicians, physician ass...

Eating Disorder Hope

CHADD

CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder) is the leading resource on attention-deficit/hyperactivity disorder (ADHD), providing support, training, education and advocacy for the 17 million children and adults in the United States living with ADHD, their families, educators and healthcare professionals. As home to the Nationa...

Hallux Incorporated

Hallux is developing an investigational micro-insert for subungual delivery and treatment of distal lateral subungual onychomycosis. The dosage form is biodegradable and delivers high concentrations of terbinafine hydrochloride directly and selectively to the site of infection over a period of time. Results from pilot studies are encouraging and suggest th...

National Eating Disorder Association

Jubilant DraxImage Inc. and Cyclopharm Limited

Jubilant DraxImage Inc., a subsidiary of Jubilant Life Sciences, develops, manufactures and commercializes radiopharmaceuticals used for the diagnosis and treatment of disease. The company is dedicated to nuclear medicine and serves customers and through them patients, globally, with high quality and reliable products and services. The company is the marke...


More From BioPortfolio on "Efficacy of Treatment for Panic Disorder"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks